Common indications for pediatric antibiotic prophylaxis

Matthew B Laurens1

  • 1Pediatric Infectious Diseases and Tropical Pediatrics, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA. mlaurens@medicine.umaryland.edu

Insights

Antimicrobial prophylaxis is vital for preventing infections in children, but requires careful physician prescribing in emergency and pediatric settings. This review covers key indications like exposures and wounds to guide appropriate antibiotic use.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial prophylaxis is standard for preventing infections in hospitals.
  • Automated systems for prophylaxis are lacking in pediatric emergency and acute care settings.
  • Physicians must ensure appropriate antibiotic prescribing for pediatric patients.

Purpose of the Study:

  • To review common indications for antimicrobial prophylaxis in pediatric acute care.
  • To guide physicians on the assessment, management, and disposition of pediatric patients for prophylaxis.
  • To highlight the importance of appropriate antibiotic use in preventing pediatric infections.

Main Methods:

  • Review of common pediatric acute care indications for antimicrobial prophylaxis.
  • Analysis of assessment, management, and disposition strategies.
  • Discussion of antibiotic prescribing practices.

Main Results:

  • Identified key indications: traumatic wounds, meningococcal, pertussis, and influenza exposures.
  • Emphasized physician responsibility in prescribing antibiotics.
  • Highlighted the need for clear guidelines in pediatric settings.

Conclusions:

  • Physician-led antibiotic prescribing is crucial for pediatric antimicrobial prophylaxis.
  • Standardized approaches are needed for indications like exposures and wounds.
  • Effective prophylaxis prevents infection and complications in pediatric patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...